PUFA metabolites in umbilical cord blood may predict autism spectrum disorder

FHS
July 29, 2024
5:03 pm

Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects learning capability and social behavior of people.

Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent therapeutic activity of LNAplus™ ASO targeting NLRP3 in debilitating autoinflammatory diseases – Biotech Investments

EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Scientific publication Secarna Pharmaceuticals publishes new preclinical data in The Journal of Immunology demonstrating potent

July 7, 2023

New treatment option for endometrial cancer shows promise in phase II trial

The latest trial of a new antibody drug that delivers potent chemotherapy directly to cancer cells for patients with advanced or recurrent endometrial cancer moves

August 1, 2024

Remote FDA drug inspections: New draft guidance spells out post-pandemic specifics

One of the FDA’s biggest tools from the pandemic is here to stay, and the agency released new draft guidance on how it plans to

October 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.